User profiles for Natasha T. Strande

Natasha T. Strande

Senior Associate Consultant, Mayo
Verified email at mayo.edu
Cited by 3724

[PDF][PDF] Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria

…, T Pesaran, SE Plon, HL Rehm, NT Strande… - The American Journal of …, 2022 - cell.com
… In other words, the threshold for the supporting level of evidence was the smallest value t in
the prediction range such that for all scores s greater than or equal to t, the lower error bound …

[PDF][PDF] Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the clinical sequencing exploratory research consortium

…, S Punj, CS Richards, J Salama, NT Strande… - The American Journal of …, 2016 - cell.com
Evaluating the pathogenicity of a variant is challenging given the plethora of types of genetic
evidence that laboratories consider. Deciding how to weigh each type of evidence is difficult…

[PDF][PDF] Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the clinical genome resource

NT Strande, ER Riggs, AH Buchanan… - The American Journal of …, 2017 - cell.com
With advances in genomic sequencing technology, the number of reported gene-disease
relationships has rapidly expanded. However, the evidence supporting these claims varies …

Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population

…, UL Mirshahi, J Kim, Y Ding, SJ Magaziner, NT Strande… - Jama, 2023 - jamanetwork.com
Importance VEXAS (vacuoles, E1-ubiquitin-activating enzyme, X-linked, autoinflammatory,
somatic) syndrome is a disease with rheumatologic and hematologic features caused by …

Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing …

…, SE Plon, HL Rehm, NT Strande… - The American Journal of …, 2023 - cell.com
The American College of Medical Genetics and Genomics (ACMG)/Association for Molecular
Pathology (AMP) framework for classifying variants uses six evidence categories related to …

Organization and dynamics of the nonhomologous end-joining machinery during DNA double-strand break repair

…, G Watanabe, NT Strande… - Proceedings of the …, 2015 - National Acad Sciences
Nonhomologous end-joining (NHEJ) is a major repair pathway for DNA double-strand breaks
(DSBs), involving synapsis and ligation of the broken strands. We describe the use of in …

Nonhomologous end joining: a good solution for bad ends

CA Waters, NT Strande, DW Wyatt, JM Pryor… - DNA repair, 2014 - Elsevier
Double strand breaks pose unique problems for DNA repair, especially when broken ends
possess complex structures that interfere with standard DNA transactions. Nonhomologous …

[HTML][HTML] The fidelity of the ligation step determines how ends are resolved during nonhomologous end joining

CA Waters, NT Strande, JM Pryor, CN Strom… - Nature …, 2014 - nature.com
Nonhomologous end joining (NHEJ) can effectively resolve chromosome breaks despite
diverse end structures; however, it is unclear how the steps employed for resolution are …

[PDF][PDF] Genomic sequencing for newborn screening: results of the NC NEXUS project

…, C Gustafson, DM DeCristo, NT Strande… - The American Journal of …, 2020 - cell.com
Newborn screening (NBS) was established as a public health program in the 1960s and is
crucial for facilitating detection of certain medical conditions in which early intervention can …

[HTML][HTML] A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing

…, CM Powell, MI Roche, C Skrzynia, NT Strande… - Genetics in …, 2016 - nature.com
Purpose: As genome-scale sequencing is increasingly applied in clinical scenarios, a wide
variety of genomic findings will be discovered as secondary or incidental findings, and there …